ArticleThe oncologist2026

Matching-adjusted indirect comparisons of PARP inhibitor combinations in metastatic castration-resistant prostate cancer across key populations.

Elena Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.